Abstract
A patient with adrenoleukodystrophy was successfully treated by means of intravenous gammaglobulin injections. The clinical symptoms, especially visual loss, were apparently relieved and no neurological deterioration was observed during a 18-month period following the start of the gammaglobulin treatment.
MeSH terms
-
Adolescent
-
Adrenoleukodystrophy / diagnostic imaging
-
Adrenoleukodystrophy / drug therapy
-
Adrenoleukodystrophy / immunology*
-
Diffuse Cerebral Sclerosis of Schilder / immunology*
-
Erythrocytes / cytology
-
Erythrocytes / metabolism
-
Fatty Acids / metabolism
-
Fibroblasts / cytology
-
Fibroblasts / metabolism
-
Humans
-
Injections, Intravenous
-
Male
-
Tomography, X-Ray Computed
-
gamma-Globulins / administration & dosage
-
gamma-Globulins / therapeutic use*
Substances
-
Fatty Acids
-
gamma-Globulins